Cargando…
Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial
BACKGROUND: Dynamic hyperinflation is highly prevalent in moderate-to-severe asthma, which may significantly impede activities of daily life. We hypothesised that dynamic hyperinflation in asthma is due to inflammation of large and small airways and can be reduced by systemic anti-inflammatory treat...
Autores principales: | van der Meer, Akke-Nynke, de Jong, Kim, Hoekstra-Kuik, Aranka, Bel, Elisabeth H., ten Brinke, Anneke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365142/ https://www.ncbi.nlm.nih.gov/pubmed/34409093 http://dx.doi.org/10.1183/23120541.00738-2020 |
Ejemplares similares
-
Management of the patient with eosinophilic asthma: a new era begins
por: de Groot, Jantina C., et al.
Publicado: (2015) -
Serum periostin reflects dynamic hyperinflation in patients with asthma
por: Asano, Takamitsu, et al.
Publicado: (2020) -
Cardiovascular effects of exercise induced dynamic hyperinflation in COPD patients—Dynamically hyperinflated and non-hyperinflated subgroups
por: Lukacsovits, Jozsef, et al.
Publicado: (2023) -
Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy
por: Eger, Katrien, et al.
Publicado: (2021) -
SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma
por: van Bragt, Job J.M.H., et al.
Publicado: (2021)